Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ACTIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | ACTIN |
| Key Genes/Proteins | 4E-BP1, ABCA1, ABCD3, ABCG1, ACTB, ALZHEIMER DISEASE |
| Related Diseases | ALS, ATHEROSCLEROSIS |
Knowledge base pages for this entity
graph TD
ACTIN["ACTIN"]
style ACTIN fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
ACTIN -->|"interacts"| Dementia["Dementia"]
ACTIN -->|"interacts"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
ACTIN -->|"interacts"| Als["Als"]
ACTIN -.->|"inhibits"| Atherosclerosis["Atherosclerosis"]
ACTIN -->|"interacts"| Alzheimer["Alzheimer"]
ACTIN -->|"interacts"| Frontotemporal_Dementia["Frontotemporal Dementia"]
ACTIN -->|"interacts"| Parkinson["Parkinson"]
ACTIN -.->|"protects against"| Neurodegeneration["Neurodegeneration"]
PIEZO1([PIEZO1]) -->|"regulates"| ACTIN
FUS([FUS]) -->|"interacts"| ACTIN
TAX1BP1([TAX1BP1]) -->|"interacts"| ACTIN
ALS([ALS]) -->|"interacts"| ACTIN
TOLLIP([TOLLIP]) -->|"interacts"| ACTIN
G3BP1([G3BP1]) -->|"interacts"| ACTIN
ULK1([ULK1]) -->|"interacts"| ACTIN
DEMENTIA([DEMENTIA]) -->|"interacts"| ACTIN
GFP([GFP]) -->|"interacts"| ACTIN
CALCOCO2([CALCOCO2]) -->|"interacts"| ACTIN| Target | Relation | Type | Str |
|---|---|---|---|
| macrophage activation | drives | process | 0.80 |
| microtubule | interacts_with | protein | 0.75 |
| Bipolar | therapeutic_target | disease | 0.60 |
| Aging | inhibits | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.60 |
| Stroke | activates | disease | 0.60 |
| Depression | activates | disease | 0.60 |
| Cancer | interacts_with | disease | 0.60 |
| Epilepsy | activates | disease | 0.60 |
| Necroptosis | activates | disease | 0.60 |
| Cancer | inhibits | disease | 0.60 |
| Aging | activates | disease | 0.60 |
| Necroptosis | regulates | disease | 0.60 |
| Cancer | expressed_in | disease | 0.60 |
| Als | causes | disease | 0.60 |
| Atherosclerosis | inhibits | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | interacts_with | disease | 0.60 |
| Dementia | activates | disease | 0.60 |
| Als | interacts_with | disease | 0.60 |
| Als | activates | disease | 0.60 |
| Alzheimer | interacts_with | disease | 0.60 |
| Huntington | activates | disease | 0.60 |
| Parkinson | inhibits | disease | 0.60 |
| Als | inhibits | disease | 0.60 |
| Parkinson | interacts_with | disease | 0.60 |
| Als | transports | disease | 0.60 |
| Ischemia | regulates | disease | 0.60 |
| Fibrosis | regulates | disease | 0.60 |
| Fibrosis | activates | disease | 0.60 |
| Leukemia | activates | disease | 0.60 |
| Schizophrenia | activates | disease | 0.60 |
| Alzheimer | activates | disease | 0.60 |
| Cancer | therapeutic_target | disease | 0.60 |
| Neurodegeneration | activates | disease | 0.60 |
| Ischemia | activates | disease | 0.60 |
| Frontotemporal Dementia | activates | disease | 0.60 |
| Tauopathy | stabilizes | disease | 0.60 |
| Alzheimer | stabilizes | disease | 0.60 |
| Parkinson | activates | disease | 0.60 |
| Neurodegeneration | protects_against | disease | 0.60 |
| Frontotemporal Dementia | associated_with | disease | 0.60 |
| Dementia | associated_with | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.60 |
| Als | expressed_in | disease | 0.60 |
| Cancer | activates | disease | 0.60 |
| Aging | degrades | disease | 0.60 |
| Ischemia | associated_with | disease | 0.60 |
| Frontotemporal Dementia | interacts_with | disease | 0.60 |
| Dementia | interacts_with | disease | 0.60 |
| Migraine | activates | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PIEZO1 | interacts_with | gene | 0.85 |
| Piezo1 | positively_regulates | gene | 0.70 |
| PIEZO1 | regulates | protein | 0.64 |
| CCND1 | associated_with | gene | 0.60 |
| GPNMB | activates | gene | 0.60 |
| FAM83A | associated_with | gene | 0.60 |
| GSK3B | associated_with | gene | 0.60 |
| AXIN | associated_with | gene | 0.60 |
| RAB35 | stabilizes | gene | 0.60 |
| AXIN2 | associated_with | gene | 0.60 |
| RAB7A | associated_with | gene | 0.60 |
| TSPAN1 | associated_with | gene | 0.60 |
| TCF4 | associated_with | gene | 0.60 |
| ALZHEIMER | stabilizes | gene | 0.60 |
| RAB7A | stabilizes | gene | 0.60 |
| TAU | stabilizes | gene | 0.60 |
| RAS | associated_with | gene | 0.60 |
| LYSOSOME | stabilizes | gene | 0.60 |
| ENDOSOME | stabilizes | gene | 0.60 |
| TAUOPATHY | stabilizes | gene | 0.60 |
| CHMP6 | stabilizes | gene | 0.60 |
| TSG101 | stabilizes | gene | 0.60 |
| DRD2 | activates | gene | 0.60 |
| SLC6A2 | activates | gene | 0.60 |
| SLC6A3 | activates | gene | 0.60 |
| SNCA | activates | gene | 0.60 |
| SLC6A4 | activates | gene | 0.60 |
| ABCB1 | activates | gene | 0.60 |
| NUCKS1 | activates | gene | 0.60 |
| CYP2D6 | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| LRRK2 | activates | gene | 0.60 |
| LAMP1 | associated_with | gene | 0.60 |
| GCH1 | activates | gene | 0.60 |
| SIRT1 | regulates | gene | 0.60 |
| NAMPT | regulates | gene | 0.60 |
| NAD | associated_with | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| LIF | activates | gene | 0.60 |
| HEDGEHOG | activates | gene | 0.60 |
| HIPPO | activates | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| IL-6 | expressed_in | gene | 0.60 |
| OCLN | interacts_with | gene | 0.60 |
| POSTN | activates | gene | 0.60 |
| PIEZO1 | expressed_in | gene | 0.60 |
| CRH | interacts_with | gene | 0.60 |
| CRH | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Microglial priming is primarily epigenetic, with metabolic c | 0.609 | neuroinflammation | Do microglia actually switch between gly |
| Structure-interacting small molecules that stabilize the APO | 0.580 | neuroscience | APOE4-driven lipid metabolism dysregulat |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Longitudinal dietary change analysis and ADRD risk over 10 years | clinical | Alzheimer's disease and relate | 0.930 | 0.00 | human patients | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ACTIN in their description or question text
No additional research found